Sheela Upadhyaya | Life Science Advisor in Rare Diseases & Special Advisor
Openflex Ltd

Day 1 - Wednesday 28 October @ 16:10

Panel: Issues on how to characterise rare diseases

Invited: 

Senior HTA Representative

Senior Clinician

Senior Geneticist 

Day 2 - Wednesday 29 October @ 12:00

Panel: Implications of EU HTA Joint Clinical Assessments to Patient Engagement Practices in Rare Diseases

This panel will explore the practical implications that industry and patient organizations need to consider when engaging given the evolving landscape of HTA in Europe

Moderator: Veronica Lopez Gousset, Independent Consultant, VLG Consulting

Patrick Hopkinson, Managing Director, 'International HTA Expert

×

Patrick Hopkinson / Panel: Implications of EU HTA Joint Clinical Assessments to Patient Engagement Practices in Rare Diseases

Patrick Hopkinson, Managing Director,
'International HTA Expert

Patrick Hopkinson is a Global Market Access/ HEOR expert with over 25 years experience. He is an independent consultant, founder and managing director of PHTA Consulting.  He is a senior leader in the life sciences industry with extensive expertise gained from working across multiple functions in...

CloseMore

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Openflex Ltd